SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Eli Lilly
LLY 1,077+0.5%9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: D.J.Smyth who wrote (196)5/1/1998 2:03:00 PM
From: Bull-like  Read Replies (1) of 642
 
Darrel and Anthony and all. Exactly! Agree 100%! These Anal-ysts are crooks to begin with. And how can you accumulate without the "buy". It is all mind game they are playing with the small investors, making them to sell so that their own clients can buy them at lower prices. If the Anal-ysts are so good at predicting the market or stock movements, why are they still working right now!

As for the competition to Viagara, I think it's going to be very difficult. Sildenfile citrate is a very potent and very, very selective PDE5 inhibitor. Believe me, I know. ICOS may be working on a similar drug. However, working along the same route of PDE5 inhibitors will run into the great risk of patent infringement. From what I heard, the patent of viagra is iron-clad. Choosing a different drug target from a different pathway means years away from clinical trials. I wouldn't bank on them. Zonagen? It's a mess. I won't touch it with 10-foot pole.

JMHO.

Da bull
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext